레이블이 Types of Cancer Treatments인 게시물을 표시합니다. 모든 게시물 표시
레이블이 Types of Cancer Treatments인 게시물을 표시합니다. 모든 게시물 표시

2013년 12월 3일 화요일

오후 7:33

By Margit Eudy

In: , , , , , , ,

No comments

About 'therapy cancer'|Promising T-cell Therapy for Leukemia and other cancers - Event May 30







About 'therapy cancer'|Promising T-cell Therapy for Leukemia and other cancers - Event May 30








Ｎｏｒｍａｌ               ｃｅｌｌｓ               ｉｎ               ｔｈｅ               ｈｕｍａｎ               ｂｏｄｙ               ｇｒｏｗ,               ｄｉｖｉｄｅ               ａｎｄ               ｅｖｅｎｔｕａｌｌｙ               ｄｉｅ.

Ｈｏｗｅｖｅｒ,               ｃａｎｃｅｒ               ｃｅｌｌｓ               ｃｏｎｔｉｎｕｅ               ｔｏ               ｇｒｏｗ               ａｎｄ               ｄｉｖｉｄｅ               ｏｕｔ               ｏｆ               ｃｏｎｔｒｏｌ               ａｎｄ               ｎｅｖｅｒ               ｄｉｅ.

Ｇｒｏｕｐ               ｏｆ               ｃａｎｃｅｒ               ｃｅｌｌｓ               ｆｏｒｍ               ｔｕｍｏｒｓ               ａｎｄ               ｄａｍａｇｅ               ｈｅａｌｔｈｙ               ｔｉｓｓｕｅｓ.

Ｗｈｅｎ               ｃａｎｃｅｒ               ｓｐｒｅａｄｓ               ｆｒｏｍ               ｔｈｅ               ｐｌａｃｅ               ｏｆ               ｏｒｉｇｉｎ               ｔｏ               ｏｔｈｅｒ               ｐａｒｔｓ               ｏｆ               ｔｈｅ               ｂｏｄｙ               ｃａｌｌｅｄ               ｍｅｔａｓｔａｓｉｓ.

Ｃａｎｃｅｒ               ｃａｎ               ｌｅａｄ               ｔｏ               ｄｅａｔｈ.

Ｉｆ               ｄｉａｇｎｏｓｅｄ               ｌａｔｅ               ｏｒ               ｈａｓ               ｓｐｒｅａｄ               ｔｏ               ｏｔｈｅｒ               ｐａｒｔｓ               ｏｆ               ｔｈｅ               ｂｏｄｙ,               ｌｅｓｓ               ｌｉｋｅｌｙ               ｔｒｅａｔａｂｌｅ.

Ｔｈｅ               ｃａｕｓｅ               ｏｆ               ｃａｎｃｅｒ               ｉｎ               ｍｏｓｔ               ｃａｓｅｓ               ｒｅｍａｉｎｓ               ｕｎｋｎｏｗｎ.

Ｍｅｎ               ｈａｖｅ               ａ               ｐｒｏｓｔａｔｅ               ｇｌａｎｄ,               ｌｏｃａｔｅｄ               ｂｅｌｏｗ               ｔｈｅ               ｂｌａｄｄｅｒ               ａｎｄ               ｉｎ               ｆｒｏｎｔ               ｏｆ               ｔｈｅ               ｒｅｃｔｕｍ.

Ａ               ｔｕｂｅ               ｃａｒｒｉｅｓ               ｕｒｉｎｅ               (ｔｈｅ               ｕｒｅｔｈｒａ)               ｔｒａｖｅｌｓ               ｔｈｒｏｕｇｈ               ｔｈｅ               ｐｒｏｓｔａｔｅ.

Ｉｆ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｇｒｏｗｓ               ｔｏ               ｌａｒｇｅ,               ｔｈｅ               ｆｌｏｗ               ｏｆ               ｕｒｉｎｅ               ｃａｎ               ｂｅ               ｓｌｏｗｅｄ               ｏｒ               ｓｔｏｐｐｅｄ.

Ｔｈｅ               ｇｌａｎｄ               ｐｒｏｄｕｃｅｓ               ｓｅｍｉｎａｌ               ｆｌｕｉｄ               ｔｈａｔ               ｎｏｕｒｉｓｈｅｓ               ａｎｄ               ｔｒａｎｓｐｏｒｔ               ｓｐｅｒｍ.

Ｎｅａｒｌｙ,               ａｌｌ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒｓ,               ｓｔａｒｔ               ｉｎ               ｔｈｅ               ｇｌａｎｄ               ｃｅｌｌｓ,               ｋｎｏｗｎ               ａｓ               ａｄｅｎｏｃａｒｃｉｎｏｍａ.

Ｔｈｅ               ｐｒｏｓｔａｔｅ               ｇｌａｎｄ               ｐｒｏｄｕｃｅｓ               ｐｒｏｓｔａｔｅ               -               ｓｐｅｃｉｆｉｃ               ａｎｔｉｇｅｎ               (ＰＳＡ)               ｉｎｔｏ               ｔｈｅ               ｂｌｏｏｄｓｔｒｅａｍ.

ＰＳＡ               ｔｅｓｔ               ｄｅｔｅｃｔｓ               ｅａｒｌｙ               ｓｃｒｅｅｎｉｎｇ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ.

Ｈｉｇｈ               ＰＳＡ               ｔｅｓｔ               ｒｅｓｕｌｔ               ｉｎｄｉｃａｔｅｓ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｉｓ               ｅｎｌａｒｇｅｄ,               ｉｎｆｅｃｔｅｄ               ｏｒ               ｄｉｓｅａｓｅｄ.

Ｉｆ               ｔｈｅ               ＰＳＡ               ｌｅｖｅｌ               ｉｓ               ａｂｏｖｅ               10               ｎｇ/ＭＬ               (Ｎａｎｏｇｒａｍｓ               ｐｅｒ               ｍｉｌｌｉｌｉｔｅｒ),               ｃｈａｎｃｅ               ｏｆ               ｈａｖｉｎｇ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｉｓ               ｈｉｇｈｅｒ               ｔｈａｎ               ｆｉｆｔｙ               ｐｅｒｃｅｎｔ               ａｎｄ               ｐｏｔｅｎｔｉａｌｌｙ               ｔｈｅ               ｃａｎｃｅｒ               ｈａｓ               ｓｐｒｅａｄ               ｂｅｙｏｎｄ               ｔｈｅ               ｐｒｏｓｔａｔｅ.

Ｍｏｓｔ               ｍｅｎ               ａｇｅ               40               ｏｒ               ｏｌｄｅｒ,               ｓｈｏｕｌｄ               ｈａｖｅ               ＰＳＡ               ｌｅｖｅｌｓ               ｕｎｄｅｒ               ｆｏｕｒ               ｎｇ/ｍＬ               ｏｆ               ｂｌｏｏｄ.

Ａｌｓｏ,               ｔｈｅ               ＰＳＡ               ｔｅｓｔ               ｉｓ               ｖｅｒｙ               ｈｅｌｐｆｕｌ               ｔｏ               ｓｈｏｗ               ｉｆ               ｃａｎｃｅｒ               ｔｒｅａｔｍｅｎｔ               ｉｓ               ｗｏｒｋｉｎｇ               ｏｒ               ｉｆ               ｃａｎｃｅｒ               ｈａｓ               ｃｏｍｅ               ｂａｃｋ               ａｆｔｅｒ               ｔｒｅａｔｍｅｎｔ.

Ｈｏｗｅｖｅｒ,               ａ               ｈｉｇｈ               ＰＳＡ               ｌｅｖｅｌ               ｍａｙ               ｎｏｔ               ａｌｌｏｗｓ               ｉｎｄｉｃａｔｅ               ｔｈｅ               ｐｒｅｓｅｎｃｅ               ｏｆ               ｃａｎｃｅｒ,               ｂｕｔ               ａｔｔｒｉｂｕｔｅｄ               ｔｏ               ｔａｋｉｎｇ               ｃｅｒｔａｉｎ               ｄｒｕｇｓ               ｏｒ               ｉｎｆｅｃｔｉｏｎ               ｉｎ               ｔｈｅ               ｐｒｏｓｔａｔｅ.

Ａｃｃｏｒｄｉｎｇ               ｔｏ               ｔｈｅ               Ａｍｅｒｉｃａｎ               Ｃａｎｃｅｒ               Ｓｏｃｉｅｔｙ,               Ａｆｒｉｃａｎ               -               Ａｍｅｒｉｃａｎｓ               ａｎｄ               ｍｅｎ               ｗｉｔｈ               ｆａｍｉｌｙ               ｈｉｓｔｏｒｙ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ,               ｓｈｏｕｌｄ               ｈａｖｅ               ＰＳＡ               ｔｅｓｔ               ａｔ               45               ｙｅａｒｓ               ｏｆ               ａｇｅ               ｏｒ               ｏｔｈｅｒｗｉｓｅ               ｂｅ               ｔｅｓｔｅｄ               ｂｙ               ａｇｅ               50.

Ｏｔｈｅｒ               ｆａｃｔｏｒｓ               ａｔｔｒｉｂｕｔｅｄ               ｔｏ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｉｎｃｌｕｄｅ               ｄｉｅｔ               (ｈｉｇｈ               ｆａｔ               ｄｉｅｔ               ａｎｄ               ｏｂｅｓｉｔｙ),               ｔｈｅ               ｅｎｖｉｒｏｎｍｅｎｔ,               ａｎｄ               ｔｅｓｔｏｓｔｅｒｏｎｅ               ｔｈｅｒａｐｙ.

Ｈｉｇｈ               ＰＳＡ               ｔｅｓｔ               ｒｅｓｕｌｔ               ｍａｙ               ｒｅｑｕｉｒｅ               ｆｕｒｔｈｅｒ               ａｓｓｅｓｓｍｅｎｔ               ａｎｄ               ｔｅｓｔｉｎｇ,               ｉｎｃｌｕｄｉｎｇ               ａ               ｐｒｏｓｔａｔｉｃ               ｉｎｔｒａｅｐｉｔｈｅｌｉａｌ               ｎｅｏｐｌａｓｉａ               (ＰＩＮ)               ｂｉｏｐｓｙ               ｔｅｓｔ,               ｍｅａｓｕｒｅｓ               ｔｈｅ               ｓｉｚｅ               ａｎｄ               ｓｈａｐｅ               ｏｆ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｇｌａｎｄ               ｃｅｌｌｓ.

ＰＩＮ               ｔｅｓｔ               ｒｅｓｕｌｔ               ｉｓ               ｍｅａｓｕｒｅｄ               ｆｒｏｍ               ｌｏｗ               ｔｏ               ｈｉｇｈ               ｇｒａｄｅ.

Ａ               ｈｉｇｈ               ｇｒａｄｅ               ＰＩＮ               ｉｎｄｉｃａｔｅｓ               ａ               ｇｒｅａｔｅｒ               ｃｈａｎｃｅ,               ｐｒｅｓｅｎｃｅ               ｏｆ               ｃａｎｃｅｒ               ｃｅｌｌｓ               ｉｎ               ｔｈｅ               ｐｒｏｓｔａｔｅ.

Ａｌｓｏ,               ｔｒａｎｓｃｒｅｃｔａｌ               ｕｌｔｒａｓｏｕｎｄ               ｅｖａｌｕａｔｅｓ               ｔｈｅ               ｐｒｏｓｔａｔｅ,               ｂｙ               ｉｎｓｅｒｔｉｎｇ               ａ               ｓｍａｌｌ               ｔｕｂｅ               ｉｎｔｏ               ｔｈｅ               ｒｅｃｔｕｍ.

Ｔｈｅ               ｐｒｏｂｅ               ｕｓｅｓ               ｓｏｕｎｄ               ｗａｖｅｓ               ｔｏ               ｇｅｔ               ａ               ｐｉｃｔｕｒｅ               ｏｆ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｇｌａｎｄ.

Ｉｎ               ｔｈｅ               Ｕｎｉｔｅｄ               Ｓｔａｔｅｓ,               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｉｓ               ｔｈｅ               ｍｏｓｔ               ｃｏｍｍｏｎ               ｔｙｐｅ               ｏｆ               ｃａｎｃｅｒ               ｆｏｕｎｄ               ｉｎ               ｍｅｎ.

Ｔｈｅ               Ａｍｅｒｉｃａｎ               Ｃａｎｃｅｒ               Ｓｏｃｉｅｔｙ               ｅｘｐｅｃｔｓ               ｉｎ               2007,               ａｐｐｒｏｘｉｍａｔｅｌｙ               218,900               ｎｅｗ               ｃａｓｅｓ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｗｉｌｌ               ｂｅ               ｄｉａｇｎｏｓｅｄ               ａｎｄ               ａｂｏｕｔ               27,050               ｍｅｎ               ｗｉｌｌ               ｄｉｅ               ｏｆ               ｔｈｉｓ               ｄｉｓｅａｓｅ.

Ｆｏｒｔｕｎａｔｅｌｙ,               ｔｈｅ               ｒａｔｅ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｄｉｓｅａｓｅ               ｈａｓ               ｂｅｅｎ               ｄｅｃｌｉｎｉｎｇ,               ｂｅｃａｕｓｅ               ｅａｒｌｙ               ｄｅｔｅｃｔｉｏｎ               ａｎｄ               ｄｕｒｉｎｇ               ｍｅｄｉｃａｌ               ｅｘａｍｉｎａｔｉｏｎ:               Ｄｏｃｔｏｒ               ｃａｎ               ｆｅｅｌ               ｉｆ               ｔｈｅｒｅ               ａｒｅ               ａｎｙ               ｂｕｍｐｓ               ｏｒ               ｈａｒｄ               ｐｌａｃｅｓ               ｉｎ               ｔｈｅ               ｐｒｏｓｔａｔｅ,               ｍａｙ               ｉｎｄｉｃａｔｅ               ｃａｎｃｅｒ               (Ｄｉｇｉｔａｌ               ｒｅｃｔａｌ               ｅｘａｍ               -               ＤＲＥ).

Ｓｙｍｐｔｏｍｓ               ｏｆ               ａｄｖａｎｃｅｄ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｉｎｃｌｕｄｅ:               Ｐａｉｎ               ｉｎ               ｔｈｅ               ｓｐｉｎｅ,               ｒｉｂｓ               ｏｒ               ｏｔｈｅｒ               ｂｏｎｅｓ,               ｂｌｏｏｄ               ｉｎ               ｔｈｅ               ｕｒｉｎｅ,               ｔｒｏｕｂｌｅ               ｈａｖｉｎｇ               ｏｒ               ｋｅｅｐｉｎｇ               ａｎ               ｅｒｅｃｔｉｏｎ,               ｌｏｓｓ               ｏｆ               ｂｌａｄｄｅｒ               ｏｒ               ｂｏｗｌ               ｃｏｎｔｒｏｌ               ａｎｄ               ｗｅａｋｎｅｓｓ               ｏｒ               ｎｕｍｂｎｅｓｓ               ｉｎ               ｔｈｅ               ｌｅｇｓ               ｏｒ               ｆｅｅｔ.
               Ｔｈｅ               ｍｏｓｔ               ｃｏｍｍｏｎ               ｔｒｅａｔｍｅｎｔ               ｆｏｒ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｉｎｃｌｕｄｅｓ               ｓｕｒｇｅｒｙ,               ｒａｄｉａｔｉｏｎ               (Ｉｍｐｌａｎｔｉｎｇ               ｉｎｔｏ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｆｏｒｔｙ               ｔｏ               ｈｕｎｄｒｅｄ               ｒｉｃｅ-ｓｉｚｅｄ               ｒａｄｉｏａｃｔｉｖｅ               ｓｅｅｄｓ.

Ｄｅｌｉｖｅｒｉｎｇ               ａ               ｈｉｇｈ               ｄｏｓｅ               ｏｆ               ｒａｄｉａｔｉｏｎ               ｏｖｅｒ               ａ               ｓｕｂｓｔａｎｔｉａｌ               ｐｅｒｉｏｄ               ｏｆ               ｔｉｍｅ.

Ｍｏｓｔ               ｅｆｆｅｃｔｉｖｅ               ｔｒｅａｔｉｎｇ               ｓｍａｌｌ               ｏｒ               ｍｏｄｅｒａｔｅ               ｓｉｚｅ               ｐｒｏｓｔａｔｅ,               ｗｉｔｈ               ｓｍａｌｌ               ａｎｄ               ｌｏｗｅｒ               ｇｒａｄｅ               ｃａｎｃｅｒｓ.),               ｈｏｒｍｏｎｅ               ｔｈｅｒａｐｙ               ａｎｄ               ｈｅｒｂａｌ               ｐｒｏｄｕｃｔｓ.

Ｔｈｅ               ｔｙｐｅ               ｏｆ               ｔｒｅａｔｍｅｎｔ               ｏｆｔｅｎ               ｄｅｐｅｎｄｓ               ｏｎ               ａｇｅ,               ｏｖｅｒａｌｌ               ｈｅａｌｔｈ,               ｓｔａｇｅ               ａｎｄ               ｇｒａｄｅ               ｏｆ               ｔｈｅ               ｃａｎｃｅｒ               ａｎｄ               ｕｎｄｅｒｓｔａｎｄｉｎｇ               ｔｈｅ               ｓｉｄｅ               ｅｆｆｅｃｔｓ               ｏｆ               ｖａｒｉｏｕｓ               ｔｒｅａｔｍｅｎｔ               ｏｐｔｉｏｎｓ.

Ｉｎ               ｓｏｍｅ               ｃａｓｅｓ,               ｔｒｅａｔｍｅｎｔ               ｍａｙ               ｃａｕｓｅ               ａ               ｐａｔｉｅｎｔ               ｔｏ               ｂｅｃｏｍｅ               ｉｎｃｏｎｔｉｎｅｎｔ               ｏｒ               ｉｍｐｏｔｅｎｔ,               ｂｕｔ               ｔｈｅｒａｐｉｅｓ               ｏｆｆｅｒ               ｈｅｌｐ               ｏｒ               ｔｒｅａｔ               ｔｈｅｓｅ               ｃｏｎｄｉｔｉｏｎｓ.
               Ｉｎ               Ｆｅｂｒｕａｒｙ               2007,               ｄｕｒｉｎｇ               ｔｈｅ               ｓｅｖｅｎｔｅｅｎｔｈ               Ｉｎｔｅｒｎａｔｉｏｎａｌ               Ｐｒｏｓｔａｔｅ               Ｃａｎｃｅｒ               Ｕｐｄａｔｅ               Ｃｏｎｆｅｒｅｎｃｅ               ｉｎ               Ｖａｉｌ,               Ｃｏｌｏｒａｄｏ,               ｒｅｓｅａｒｃｈｅｒｓ               ｐｒｅｓｅｎｔｅｄ               (Ｂｅｔｗｅｅｎ               Ｐｒｏｓｔａｔｅ               Ｃａｎｃｅｒ               Ｒｅｓｅａｒｃｈ               ａｎｄ               Ｅｄｕｃａｔｉｏｎ               Ｆｏｕｎｄａｔｉｏｎ               ａｎｄ               Ｍｅｄｌｎｓｉｇｈｔ               Ｒｅｓｅａｒｃｈ               Ｉｎｓｔｉｔｕｔｅ)               ｓｔｕｄｙ,               ｃｏｎｆｉｒｍｅｄ               Ｎｏｓｃａｐｉｎｅ               (Ｎａｒｃｏｔｉｎｅ)               ａ               ｎｏｎ-ａｄｄｉｃｔｉｖｅ               ｄｅｒｉｖａｔｉｖｅ               ｏｆ               ｏｐｉｕｍ               ｕｓｅｄ               ｗｏｒｌｄｗｉｄｅ               ａｓ               ａｎ               ａｎｔｉ-ｃｏｕｇｈ               ｍｅｄｉｃａｔｉｏｎ               (ｏｖｅｒ               ｔｈｅ               ｃｏｕｎｔｅｒ)               ａｆｆｅｃｔｉｖｅ               ｔｒｅａｔｉｎｇ               ｔｕｍｏｒｓ               ｉｎ               ａｎｉｍａｌｓ.

Ｐｒｅｖｉｏｕｓｌｙ               ｒｅｐｏｒｔｅｄ               (1999),               ｒｅｓｅａｒｃｈｅｒｓ               ａｔ               Ｅｍｏｒｙ'ｓ               Ｓｃｈｏｏｌ               ｏｆ               Ｍｅｄｉｃｉｎｅ               ｒｅｐｏｒｔｅｄ               ｎｏｓｃａｐｉｎｅ               ｄｒａｍａｔｉｃａｌｌｙ               ｒｅｄｕｃｅｄ               ｔｈｅ               ｓｉｚｅ               ｏｆ               ｂｒｅａｓｔ               ｔｕｍｏｒｓ               ｉｎ               ｌａｂ               ｍｉｃｅ,               ｅｌｉｍｉｎａｔｉｎｇ               ｔｕｍｏｒｓ               ｅｎｔｉｒｅｌｙ,               ａｎｄ               ａｆｆｅｃｔｉｖｅ               ａｇａｉｎｓｔ               ｂｌａｄｄｅｒ               ｔｕｍｏｒｓ.

Ｄｒ.

Ｉｓｒａｅｌ               Ｂａｒｋｅｎ,               Ｆｏｕｎｄｅｒ               ａｎｄ               Ｍｅｄｉｃａｌ               Ｄｉｒｅｃｔｏｒ               ｏｆ               ｔｈｅ               Ｐｒｏｓｔａｔｅ               Ｃａｎｃｅｒ               Ｒｅｓｅａｒｃｈ               ａｎｄ               Ｅｄｕｃａｔｉｏｎａｌ               Ｆｏｕｎｄａｔｉｏｎ               ｉｎ               Ｓａｎ               Ｄｉｅｇｏ,               Ｃａｌｉｆｏｒｎｉａ,               ｏｖｅｒ               ａ               ｄｅｃａｄｅ               ｕｓｅｄ               ｎｏｓｃａｐｉｎｅ               ｆｏｒ               ｔｒｅａｔｉｎｇ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ.

Ｄｒ.

Ｂａｒｋｅｎ               ｓａｉｄ:               "Ｉｎ               ｏｕｒ               ｓｔｕｄｙ               ｎｏｓｃａｐｉｎｅ               ａｄｍｉｎｉｓｔｅｒｅｄ               ｏｒａｌｌｙ               ｔｏ               ａｎｉｍａｌｓ               ｈａｄ               ａ               ｔｕｍｏｒ               ｉｎｈｉｂｉｔｉｏｎ               ｒａｔｅ               ｏｆ               60%               ａｎｄ               ｒｅｄｕｃｅｄ               ｍｅｔａｓｔａｓｉｓ               ｂｙ               ｊｕｓｔ               ｏｖｅｒ               65%.

Ｉｎｃｒｅｄｉｂｌｙ,               ｔｈｉｓ               ｗａｓ               ａｃｈｉｅｖｅｄ               ｗｉｔｈ               ｎｏ               ｔｏｘｉｃｉｔｙ               ｔｈｕｓ               ｄｅｍｏｎｓｔｒａｔｉｎｇ               ｎｏｓｃａｐｉｎｅ'ｓ               ｐｏｔｅｎｔｉａｌ               ｎｏｔ               ｏｎｌｙ               ａｓ               ａｎ               ｅｆｆｅｃｔｉｖｅ               ａｎｔｉｃａｎｃｅｒ               ａｇｅｎｔ,               ｂｕｔ               ａ               ｖｅｒｙ               ｓａｆｅ               ｏｎｅ               ｔｏｏ."               Ｄｒ.

Ｂａｒｋｅｒ               ｐｌａｎｓ               ｔｏ               ｃｏｏｒｄｉｎａｔｅ               ｃｌｉｎｉｃａｌ               ｔｒｉａｌｓ,               ａｎｄ               ｔｒｅａｔｍｅｎｔ               ｏｆ               ｎｏｓｃａｐｉｎｅ               ｉｎ               ｐａｔｉｅｎｔｓ               ｓｕｆｆｅｒｉｎｇ               ｆｒｏｍ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ａｎｄ               ｔｈｒｏｕｇｈ               ｈｉｓ               ｗｏｒｋ,               ｐｉｏｎｅｅｒｉｎｇ               ａ               ｗｅｂ               ｂａｓｅｄ               ｐａｔｉｅｎｔ               ｔｒａｃｋｉｎｇ               ｓｙｓｔｅｍ,               ｅｓｔａｂｌｉｓｈｉｎｇ               ａ               ｇｌｏｂａｌ               ｐａｒｔｉｃｉｐａｔｉｏｎ               ｏｆ               ｐａｔｉｅｎｔｓ               ａｎｄ               ｔｈｕｓ               ａｃｈｉｅｖｅ               ｆａｓｔｅｒ               ｒｅｓｕｌｔｓ.

Ｂｅｓｉｄｅｓ               ｔｈｅ               ｐｏｔｅｎｔｉａｌ               ｔｒｅａｔｍｅｎｔ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ,               Ｉｒａｎｉａｎ               ｓｃｉｅｎｔｉｓｔｓ               ｈａｖｅ               ｓｈｏｗｎ               ｎｏｓｃａｐｉｎｅ               ａｆｆｅｃｔｉｖｅ               ｉｎ               ｔｒｅａｔｉｎｇ               ｓｔｒｏｋｅｓ.

Ｎｏｓｃａｐｉｎｅ               ｐｏｓｓｉｂｌｅ               ｓｉｄｅ               --               ｅｆｆｅｃｔｓ:               Ｌｏｓｓ               ｏｆ               ａｐｐｅｔｉｔｅ,               ｉｎｃｒｅａｓｅｄ               ｈｅａｒｔ               ｒａｔｅ,               ｌｏｓｓ               ｏｆ               ｃｏｏｒｄｉｎａｔｉｏｎ,               ｌｏｓｓ               ｏｆ               ｓｅｘｕａｌ               ｄｒｉｖｅ,               ｌｏｓｓ               ｏｆ               ｓｌｅｅｐｉｎｅｓｓ,               ａｎｄ               ｓｈａｋｉｎｇ               ａｎｄ               ｍｕｓｃｌｅ               ｓｐａｓｍｓ.

Ｈｏｗｅｖｅｒ,               ｔｈｅ               ｃｏｕｇｈ               ｓｕｐｐｒｅｓｓａｎｔ               ａｐｐｅａｒｓ               ｔｏ               ｈａｖｅ               ｆｅｗ               ｏｆ               ｔｈｅ               ｕｎｐｌｅａｓａｎｔ               ｓｉｄｅ               ａｆｆｅｃｔｓ               ｃｏｍｍｏｎ               ｔｏ               ｍｏｓｔ               
               ａｎｔｉ               --               ｔｕｍｏｒ               ｃｏｍｐｏｕｎｄｓ.
               Ｉｎ               Ｆｅｂｒｕａｒｙ               2007,               ＧＰＣ               Ｂｉｏｔｅｃｈ               ＡＧ               (Ｇｅｒｍａｎ               ｐｈａｒｍａｃｅｕｔｉｃａｌ               ｃｏｍｐａｎｙ               ａｎｄ               ｉｔｓ               Ｕｎｉｔｅｄ               Ｓｔａｔｅｓ               ｏｐｅｒａｔｉｏｎｓ               ｉｎ               Ｍａｓｓａｃｈｕｓｅｔｔｓ               ａｎｄ               Ｐｒｉｎｃｅｔｏｎ,               Ｎｅｗ               Ｊｅｒｓｅｙ),               ａｐｐｌｉｅｄ               ｔｏ               ｔｈｅ               Ｆｏｏｄ               ａｎｄ               Ｄｒｕｇ               Ａｄｍｉｎｉｓｔｒａｔｉｏｎ,               ａｐｐｌｉｃａｔｉｏｎ               ｔｏ               ｇａｉｎ               ａｐｐｒｏｖａｌ               ｏｆ               ｉｔｓ               ｄｒｕｇ               ｓａｔｒａｐｌａｔｉｎ               ａｓ               ａ               ｔｒｅａｔｍｅｎｔ               ｆｏｒ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ,               ｉｎ               ｐａｔｉｅｎｔｓ               ｗｅｒｅ               ｐｒｉｏｒ               ｃｈｅｍｏｔｈｅｒａｐｙ               ｔｒｅａｔｍｅｎｔｓ               ｆａｉｌｅｄ.

Ｔｈｅ               ＦＤＡ               ｈａｓ               ｇｒａｎｔｅｄ               ｆａｓｔ               ｔｒａｃｋ               ｄｅｓｉｇｎａｔｉｏｎ,               ｅｘｐｅｄｉｔｉｎｇ               ｒｅｖｉｅｗ               ｏｆ               ｔｈｅ               ｄｒｕｇ.

Ｄｕｒｉｎｇ               Ｐｈａｓｅ               ｔｈｒｅｅ               ｃｌｉｎｉｃａｌ               ｔｒｉａｌ:               Ｄｒｕｇ               ｐｒｏｌｏｎｇｅｄ               ｔｈｅ               ｓｕｒｖｉｖａｌ               ｏｆ               950               ｐａｔｉｅｎｔｓ.

Ｓａｔｒａｐｌａｔｉｎ               ｉｓ               ｏｒａｌｌｙ               ｔａｋｅｎ               ｉｎ               ｔｈｅ               ｆｏｒｍ               ｏｆ               ｃａｐｓｕｌｅｓ.

Ｔｈｅ               ｄｒｕｇ               ｉｓ               ａ               ｍｅｍｂｅｒ               ｏｆ               ｔｈｅ               ｐｌａｔｉｎｕｍ               ｆａｍｉｌｙ               ｏｆ               ｃｏｍｐｏｕｎｄｓ,               ｐａｒｔ               ｏｆ               ｔｈｅ               ｍｏｄｅｒｎ               ｃｈｅｍｏｔｈｅｒａｐｙ               ｔｒｅａｔｍｅｎｔｓ               ａｎｄ               ｔｒｅａｔ               ｗｉｄｅ               ｖａｒｉｅｔｙ               ｏｆ               ｃａｎｃｅｒｓ.

Ｔｈｅ               ａｃｔｉｏｎ               ｏｆ               ｓａｔｒａｐｌａｔｉｎ               ｂｉｎｄｓ               ｔｏ               ＤＮＡ               ｏｆ               ｃａｎｃｅｒ               ｃｅｌｌｓ               ａｎｄ               ｍａｋｅｓ               ｔｈｅ               ｃｅｌｌ               ｉｎｃａｐａｂｌｅ               ｏｆ               ｄｉｖｉｄｉｎｇ.

Ｔｈｉｓ               ｃａｕｓｅｓ               ｔｕｍｏｒｓ               ｔｏ               ｓｔｏｐ               ｇｒｏｗｉｎｇ,               ｅｖｅｎｔｕａｌｌｙ               ｌｅａｄｉｎｇ               ｔｏ               ｔｈｅ               ｄｅａｔｈ               ｏｆ               ｃａｎｃｅｒ               ｃｅｌｌｓ.

Ｄｕｒｉｎｇ               ｐｈａｓｅ               ｔｗｏ               ｃｌｉｎｉｃａｌ               ｔｒｉａｌｓ:               Ｓａｔｒａｐｌａｔｉｎ               ａｆｆｅｃｔｉｖｅ               ｔｒｅａｔｉｎｇ               ｏｖａｒｉａｎ               ａｎｄ               ｓｍａｌｌ               ｃｅｌｌ               ｌｕｎｇ               ｃａｎｃｅｒ.

Ｂｅｒｎｒｄ               Ｒ.

Ｓｅｉｚｉｎｇｅｒ               Ｍ.Ｄ.,               Ｐｈ.Ｄ.,               Ｃｈｉｅｆ               Ｅｘｅｃｕｔｉｖｅ               Ｏｆｆｉｃｅｒ               ｆｏｒ               ＧＰＣ               Ｂｉｏｔｅｃｈ               ＡＧ               ｓａｉｄ:               "               Ｗｅ               ｗｉｌｌ               ｂｅ               ｗｏｒｋ               ｃｌｏｓｅｌｙ               ｗｉｔｈ               ｔｈｅ               ＦＤＡ               ｄｕｒｉｎｇ               ｔｈｅ               ｒｅｖｉｅｗ               ｐｒｏｃｅｓｓ               ｔｏ               ｍｏｖｅ               ｔｈｅ               ａｐｐｌｉｃａｔｉｏｎ               ｆｏｒｗａｒｄ               ａｓ               ｅｘｐｅｄｉｔｉｏｕｓｌｙ               ａｓ               ｐｏｓｓｉｂｌｅ.

Ｗｅ               ｂｅｌｉｅｖｅ               ｔｈａｔ,               ｉｆ               ａｐｐｒｏｖｅｄ               ｓａｔｒａｐｌａｔｉｎ               ｈａｓ               ｔｈｅ               ｐｏｔｅｎｔｉａｌ               ｔｏ               ｂｅｃｏｍｅ               ａｎ               ｉｍｐｏｒｔａｎｔ               ｎｅｗ               ｔｒｅａｔｍｅｎｔ               ｏｐｔｉｏｎ               ｆｏｒ               ａｄｖａｎｃｅｄ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｐａｔｉｅｎｔｓ               ｗｈｏ               ｔｏｄａｙ               ｈａｖｅ               ｖｅｒｙ               ｌｉｔｔｌｅ               ｈｏｐｅ.

Ｗｅ               ａｒｅ               ｃｕｒｒｅｎｔｌｙ,               ｂｕｉｌｄｉｎｇ               ｏｕｒ               ｃｏｍｍｅｒｃｉａｌ               ｉｎｆｒａｓｔｒｕｃｔｕｒｅ               ｉｎ               ｔｈｅ               ＵＳ               ｔｏ               ｐｒｅｐａｒｅ               ｆｏｒ               ｔｈｅ               ｐｏｔｅｎｔｉａｌ               ｌａｕｎｃｈ               ｏｆ               ｓａｔｒａｐｌａｔｉｎ               ｓｏ               ｔｈａｔ               ｉｔ               ｗｉｌｌ               ｂｅ               ａｖａｉｌａｂｌｅ               ｆｏｒ               ｔｈｏｓｅ               ｐａｔｉｅｎｔｓ               ａｓ               ｑｕｉｃｋｌｙ               ａｓ               ｐｏｓｓｉｂｌｅ."
               Ｐｒｅｖｅｎｔｉｎｇ               ｔｈｅ               ｒｉｓｋ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ:               Ｅａｔｉｎｇ               ｗｅｌｌ               (Ｌｉｍｉｔｉｎｇ               ｔｈｅ               ｉｎｔａｋｅ               ｏｆ               ｈｉｇｈ               ｆａｔ               ｆｏｏｄｓ,               ａｎｄ               ｅａｔｉｎｇ               ｍｏｒｅ               ｏｆｔｅｎ               ｆｒｕｉｔｓ,               ｖｅｇｅｔａｂｌｅｓ,               ａｎｄ               ｗｈｏｌｅ               ｆｉｂｅｒｓ),               ｇｅｔｔｉｎｇ               ｒｅｇｕｌａｒ               ｅｘｅｒｃｉｓｅ,               ａｎｄ               ａｎｎｕａｌ               ｐｒｏｓｔａｔｅ               ｅｘａｍｉｎａｔｉｏｎ.

Ｉｎ               1992,               Ｔｈｅ               Ｕ.Ｓ.

Ｆｏｏｄ               ａｎｄ               Ｄｒｕｇ               Ａｄｍｉｎｉｓｔｒａｔｉｏｎ               ａｐｐｒｏｖｅｄ               ｔｈｅ               ｓａｌｅ               ａｎｄ               ｍａｒｋｅｔｉｎｇ               ｏｆ               ｆｉｎａｓｔｅｒｉｄｅ               (Ｐｒｏｓｃａｒ               Ｐｒｏｐｅｃｉａ)               ｆｏｒ               ｔｒｅａｔｉｎｇ               ｂｅｎｉｇｎ               ｐｒｏｓｔａｔｉｃ               ｈｙｐｅｒｐｌａｓｉａ               (ＢＨＰ),               ａ               ｎｏｎｃａｎｃｅｒｏｕｓ               ｅｎｌａｒｇｅｍｅｎｔ               ｏｆ               ｔｈｅ               ｐｒｏｓｔａｔｅ               ｔｈａｔ               ｃａｎ               ｂｌｏｃｋ               ｔｈｅ               ｆｌｏｗ               ｏｆ               ｕｒｉｎｅ.

Ｂｅｓｉｄｅｓ               ｔｈｅ               ｍｅｄｉｃａｔｉｏｎｓ               ｔｒｅａｔｓ               ｈａｉｒ               ｌｏｓｓ               ｉｎ               ｍｅｎ.

Ａｃｃｏｒｄｉｎｇ               ｔｏ               Ｐｒｏｓｔａｔｅ               Ｃａｎｃｅｒ               Ｐｒｅｖｅｎｔｉｏｎ               Ｔｒｉａｌ               ｆｉｎａｓｔｅｒｉｄｅ               ｒｅｄｕｃｅｓ               ｔｈｅ               ｉｎｃｉｄｅｎｃｅ               ｏｆ               ｐｒｏｓｔａｔｅ               ｃａｎｃｅｒ               ｂｙ               24.8               ｐｅｒｃｅｎｔ               ｃｏｍｐａｒｅｄ               ｔｏ               ａ               ｐｌａｃｅｂｏ,               ｏｖｅｒ               ｔｅｎ               ｙｅａｒｓ.

Ｈｏｗｅｖｅｒ,               ｐｏｓｓｉｂｌｅ               ｓｉｄｅ               ａｆｆｅｃｔ               ｉｎｃｒｅａｓｅｓ               ｔｈｅ               ｃｈａｎｃｅ               ｄｅｖｅｌｏｐｉｎｇ               ｔｕｍｏｒｓ.






Image of therapy cancer






therapy cancer
therapy cancer


therapy cancer Image 1


therapy cancer
therapy cancer


therapy cancer Image 2


therapy cancer
therapy cancer


therapy cancer Image 3


therapy cancer
therapy cancer


therapy cancer Image 4


therapy cancer
therapy cancer


therapy cancer Image 5


  • Related blog with therapy cancer





    1. menhealthnews.wordpress.com/   11/26/2013
      Therapy Combination for Prostrate Cancer Improves Survival... long-term hormonal therapy plus radical radiotherapy the... prostate cancer." Experts predict...
    2. chsolutions.typepad.com/communityhealthnews/   10/24/2013
      10/24/13 Prostate Cancer Radiation Therapy Rises as Doctors Profit Bloomberg Urologists who buy their own...
    3. hemoglobinmail.blogspot.com/   04/17/2013
      ...s Description: This is an exciting and promising leukemia/cancer therapy news event. Topics include leukemia, childhood leukemia and a promising new...
    4. www.eurekalert.org/   05/11/2012
      ...Molecular subtypes and genetic alterations may determine response to lung cancer therapy Cancer therapies targeting specific molecular subtypes of the...
    5. venturebeat.com/   04/17/2013
      ...Nanostraw” device that can reprogram human T-cells for the purposes of cancer therapy. Thiel is funneling the millions he made through early ...
    6. igaluxy.wordpress.com/   09/06/2011
      The Glorious Technology for Cancer Therapy : Nanorobots BY. Pharmacist. Farzana...novel technology or novel treatment option for Cancer Therapy. Cancer Treatment has got...
    7. internationalentertainment.blogspot.com/   04/15/2013
      ..., but other promising cancer therapies still awaiting green light... available specific to my cancer, specific to my needs," Skinner...
    8. ozoneuniversity.blogspot.com/   09/30/2013
      ...You will see this on almost any website that has to do with any oxygen therapy, here's the quote, "Cancer, above all other diseases, has countless secondary causes...
    9. embemusic.wordpress.com/   08/22/2011
      ... of music therapy. Enjoy! http://www.cbc.ca/news/health/story/2011/08/10/music-therapy-cancer.html Share this: Share Twitter Facebook LinkedIn Like this: Like Be the first to like this post...
    10. forexmetatraderplatform.blogspot.com/   11/04/2012
      ...15$ / Month Pin It now! Cancer-Free -- Cancer Therapies That Work Typical causes include... necessary to reverse their cancer. My mission is to help you join...

      11. Therapy Cancer - Blog Homepage Results

      APOLLO HOSPITALS INDIA - CYBERKNIFE THERAPYbyApollo Speciality Cancer Hospital
      http://cyberknifeindia.blogspot.com/
      Details and discussions on the recently introduced Cyberknife Robotic Radiosurgery -first in the Asia Pacific region from Apollo Hospitals
      The Three Rs of Cancer Remission~Recurrence~ResiliencebySouthernOaks
      http://wwwremission-recurrence-resilience.blogspot.com/
      ...us makes us stronger." When it comes to living with cancer, I think resilient is a more appropriate word. Chemo drugs, radiation therapy, and other treatment modes certainly don't make us stronger, but they do...
      Prostate Cancer Hormone Therapybyprostatecancerhormonetherapy
      http://prostatecancerhormonetherapy.wordpress.com/
      Prostate cancer hormone therapy focuses on reducing the levels of male hormones in...
      more Therapy Cancer Blogs



    Related Video with therapy cancer







    therapy cancer Video 1








    therapy cancer Video 2








    therapy cancer Video 3




    therapy cancer